ARCHIVES

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Gallo, Rosenberg, Bishop, Varmus Win GM Awards

June 15, 1984

Upton Prefers Keeping Bioassay Program In NCI

May 12, 1978

Salmon Enthusiastic About Comprehensive Core Grant Plan

May 6, 1988

Panel Debates Whether DCIS Needs A New Name

September 25, 2009

DD Should Transfer Part of Breast Cancer $$ To NIH r Peer Distribution, Broder Says

December 4, 1992

DCT Will Consider Planning, Center Core Supplemental, Program Project Grants In $5 Million Surgical Oncology Development Effort

October 10, 1980